國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 859551      線上人數 : 649
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版
    鄰近類別
    圖書 [4/5]
    會議論文/會議摘要 [3/4]
    專利 [0/44]

    類別統計

    近3年內發表的文件:2(2.00%)
    含全文筆數:97(97.00%)

    文件下載次數統計
    下載大於0次:97(100.00%)
    下載大於100次:97(100.00%)
    檔案下載總次數:67011(94.67%)

    最後更新時間: 2024-11-28 16:02


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-50 / 100. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2023-03-24 Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system Virus Research. 2023 Mar 24;329:Article number 199101.
    2022-09-15 The uncoating of EV71 in mature late endosomes requires CD-M6PR Biology Open. 2022 Sep 15;11(9):Article number bio059469.
    2018-05 Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture Vaccine. 2018 May;36(22):3134-3139.
    2018-04-18 Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
    2016-11-09 Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy Scientific Reports. 2016 Nov 09;6:Article number 36732.
    2016-11 Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus Microbes and Infection. 2016 Nov;18(11):706-709.
    2016-08 Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology Antiviral Research. 2016 Aug;132:225-232.
    2016-07-29 Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice Scientific Reports. 2016 Jul 29;6:Article number 30648.
    2016-07 The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection Human Vaccines and Immunotherapeutics. 2016 Jul;12(7):1678-1689.
    2016-05 Immunological and biochemical characterizations of Coxsackievirus A6 and A10 viral particles Antiviral Research. 2016 May;129:58-66.
    2016-02 Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice Vaccine. 2016 Feb;34(8):1054-1061.
    2015-12-29 The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice PLoS ONE. 2015 Dec 29;10(12):Article number e0145717.
    2015-12 Recombinant bacterial lipoproteins as vaccine candidates Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
    2015-12 Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection International Journal of Infectious Diseases. 2015 Dec;41:56-64.
    2015-11 Is a multivalent hand, foot, and mouth disease vaccine feasible? Human Vaccines and Immunotherapeutics. 2015 Nov;11(11):2688-2704.
    2015-08-13 Biochemical and immunological characterization of truncated fragments of the receptor-binding domains of C. difficile toxin A PLoS ONE. 2015 Aug 13;10(8):Article number e0135045.
    2015-08-07 Recombinant lipoprotein-based vaccine candidates against C. difficile infections Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
    2015-06 Recombinant lipoproteins as novel vaccines with intrinsic adjuvant Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
    2015-04 Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692.
    2015-03 Review of enterovirus 71 vaccines Clinical Infectious Diseases. 2015 Mar;60(5):797-803.
    Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology Human Vaccines and Immunotherapeutics. 2015 Apr;11(4):1065-1073.
    2014-11 Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250.
    2014-10 Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases Vaccine. 2014 Oct;32(47):6177-6182.
    2014-09-08 Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques PLoS ONE. 2014 Sep 8;9(9):Article number e106756.
    2014-09 A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus Journal of General Virology. 2014 Sep;95(Pt 9):1983-1990.
    2014-08-27 Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice BioMed Research International. 2014 Aug 27;2014:Article number 878139.
    2014-07-30 Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns Journal of Virology. 2014 Jul 30;88(20):11658-11670.
    2014-06-11 Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems Biomed Research International. 2014 Jun 11;2014:Article number 670506.
    2014-05 Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells Journal of Immunology. 2014 May;192(9):4233-4241.
    2014-03 Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity Vaccine. 2014 Mar;32(12):1346-1353.
    2014-03 A purified recombinant lipopeptide as adjuvant for cancer immunotherapy BioMed Research International. 2014 Mar;2014:Article number 349783.
    2014-01 A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity Journal of Controlled Release. 2014 Jan;173(1):158-165.
    2014-01 Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide Biomaterials. 2014 Jan;35(5):1686-1695.
    2013-12 The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan Journal of Microbiology, Immunology and Infection. 2013 Dec;46(6):448-455.
    2013-11-21 Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers PLoS ONE. 2013 Nov 21;8(11):Article number e79783.
    2013-11 Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385.
    2013-09-19 Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
    2013-09 Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III Microbes and Infection. 2013 Sep;15(10-11):719-728.
    2013-07-30 Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice PLoS ONE. 2013 Jul 30;8(7):Article number e69858.
    2013-07 A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates Archives of Virology. 2013 Jul;158(7):1523-1531.
    2013-06-13 Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence ACS Medicinal Chemistry Letters. 2013 Jun 13;4(6):522-526.
    2013-05 A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine Vaccine. 2013 May;31(20):2471-2476.
    2013-05 Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines Journal of Immunology. 2013 May;190(10):5065-5077.
    2013-02-25 Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71 PLoS ONE. 2013 Feb 25;8(2):Article number e57591.
    2013-01 Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells Immunobiology. 2013 Jan;218(1):90-95.
    2012-12 Production of EV71 vaccine candidates Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
    2012-11-30 Immunological and biochemical characterization of Coxsackie Virus A16 viral particles PLoS ONE. 2012 Nov 30;7(11):Article number e49973.
    2012-09 Immunological evaluation and comparison of different EV71 vaccine candidates Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.
    2012-08-28 Challenges to licensure of enterovirus 71 vaccines PLoS Neglected Tropical Diseases. 2012 Aug 28;6(8):Article number e1737.
    2012-08 CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17–Polarizing conditions Journal of Immunology. 2012 Aug;189(4):1671-1679.

    顯示項目1-50 / 100. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋